Glofitamab in Aggressive B Non-Hodgkin Lymphoma (B-NHL): A Real World Experience

被引：0
作者：
Chan, Thomas [1 ]
Kwong, Yok Lam [2 ]
Tse, Eric [3 ]
机构：
[1] Queen Mary Hosp, Hong Kong, Peoples R China
[2] Univ Hong Kong, Dept Med, Hong Kong, Peoples R China
[3] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-173916
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 2 条
[1]   Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification [J].
Cheson, Bruce D. ;
Fisher, Richard I. ;
Barrington, Sally F. ;
Cavalli, Franco ;
Schwartz, Lawrence H. ;
Zucca, Emanuele ;
Lister, T. Andrew .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3059-+
[2]   Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma [J].
Dickinson, Michael J. ;
Carlo-Stella, Carmelo ;
Morschhauser, Franck ;
Bachy, Emmanuel ;
Corradini, Paolo ;
Iacoboni, Gloria ;
Khan, Cyrus ;
Wrobel, Tomasz ;
Offner, Fritz ;
Wu, Shang-Ju ;
Cartron, Guillaume ;
Hertzberg, Mark ;
Sureda, Anna ;
Perez-Callejo, David ;
Lundberg, Linda ;
Relf, James ;
Dixon, Mark ;
Clark, Emma ;
Humphrey, Kathryn ;
Hutchings, Martin ;
Trney, Marek .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (24) :2220-2231
1